Unannounced · 163 daysFiled 6 April 2026
Ancilia Biosciences, Inc. raised $10.1M
Ancilia Biosciences, Inc., a company based in New York, NY, raised $10.1M in a new equity round, according to a filing dated 6 April 2026.
No public announcement found as of 15 September 2026, 163 days after the filing.
- Filed
- 6 April 2026
- Round
- Equity round
- Amount sold
- $10.1M
- Offering size
- $10.1M
- Investors so far
- 23
- Based in
- New York, NY
- Industry
- Other
- Website
- anciliabio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 56% of the 845 tracked raises with an amount filed in 2026.
Ancilia Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 6 Apr 2026 | New filing | $10.1M | This raise |
More with FRx on the board
- Neurofold Therapeutics Inc.$6.5M
- Contraline, Inc.$55.8M
- Junction Health, Inc.$3.54M
- Attivare Therapeutics, Inc.$5.88M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.